-
Genomic analysis for intrahepatic cholangiocarcinoma
Dataset
EGAD00001008557
-
RNA, ATAC, ChIP datasets from Ankylosing Spondylitis patients and Healthy Controls
Dataset
EGAD00001008758
-
Epithelial, fibroblast, myeloid, T cell, primary prostate cancer
Dataset
EGAD00001004948
-
Dataset for neuroendocrine_adrenal_tumor-RNA
Dataset
EGAD00001008862
-
Whole genome landscape of adult T-cell leukemia/lymphoma
Dataset
EGAD00001008289
-
WGS and WTS data of patients diagnosed with MEITL.
Dataset
EGAD00001005341
-
WTS and WES of Renal Cell Carcinoma Tumors From a Phase III Anti-Angiogenic Adjuvant Therapy Trial
Dataset
EGAD00001009294
-
CHILD Study Dataset
Dataset
EGAD00001009710
-
Genomic profiling of subcutaneous patient derived xenograft models of solid childhood cancer
Dataset
EGAD00001009863
-
Whole-exome sequencing of meningiomas for integrative molecular classification.
Dataset
EGAD00001007051
-
H3K27ac ChIP-seq in primary inflammatory macrophages from 2 minor allele homozygotes and 2 major allele homozygotes at rs2836882
Dataset
EGAD00001011351
-
Ancestry and somatic profile predict acral melanoma origin and prognosis – RNA
Dataset
EGAD00001015756
-
A DNA methylation atlas of normal human cell types
Dataset
EGAD00001009789
-
TRACERx NSCLC, multiregion sequencing of the first 100 tumors
Dataset
EGAD00001003206
-
ENOC WGS for the study Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
Dataset
EGAD00001003266
-
Whole Exome and Target Sequencing Data in 75 Samples from 5 Hepatocellular Carcinoma Patients.
Dataset
EGAD00001003278
-
HGSC WGS for the study Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
Dataset
EGAD00001003268
-
Open Targets 020 Epigenomes of Cell Lines (2018-10-23)
Dataset
EGAD00001004416
-
Distinct evolutionary trajectories of primary high grade serous ovarian cancers revealed through spatial mutational profiling
Dataset
EGAD00001000669
-
Integrated clinical, whole genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer
Dataset
EGAD00001001869
-
Expression profiling of a human endocrine pancreas iPSC model
Dataset
EGAD00001002148
-
miRNA expression data from primary tumors, metastasis and matched normals.
Dataset
EGAD00001001644
-
Cooperative activity of BRAF F595L and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling
Dataset
EGAD00001001384
-
Reference Epigenomes and Regulatory Landscape of CLL
Dataset
EGAD00001004046
-
Open Targets 020 Epigenomes of Cell Lines (2018-10-23)
Dataset
EGAD00001004413
-
Distinct evolutionary trajectories of primary high grade serous ovarian cancers revealed through spatial mutational profiling
Dataset
EGAD00001000974
-
Characterization and clinical relevance of the genomic alterations defining invasive lobular breast cancer
Dataset
EGAD00001001395
-
Characterisation of the genomic landscape of CRLF2-d ALL
Dataset
EGAD00001002008
-
Characterisation of the genomic landscape of CRLF2-d ALL
Dataset
EGAD00001002007
-
13 WGS and 8 TCS data of ENKL patients treated with pembrolizumab.
Dataset
EGAD00001004140
-
Open Targets 020 Epigenomes of Cell Lines (2018-10-23)
Dataset
EGAD00001004414
-
Co-culture experiment (hashed samples)
Study
EGAS50000001252
-
RNA-seq as a tool for evaluating human embryo competence
Dataset
EGAD00001005044
-
Single Cell Analysis of Human Airways in Healthy and Asthma volunteers
Dataset
EGAD00001005064
-
Combined MEK and BCL-2/XL inhibition is effective in high-grade serous ovarian cancer patient-derived xenograft models and BIM levels are predictive of responsiveness
Dataset
EGAD00001005111
-
Longitudinal profiling of the immune response to Plasmodium vivax in naive hosts by RNA-sequencing
Dataset
EGAD00001006924
-
A Tumour Organoid Biobank for Mapping Cancer Cell Vulnerabilities - WGS
Dataset
EGAD00001015469
-
Transcriptome Changes in ASD (NRXN1α+/-) iPSC-derived neurons
Study
EGAS00001005536
-
Metabolic profiling of patient-derived organoids reveals nucleotide synthesis as a metabolic vulnerability in malignant rhabdoid tumors
Study
EGAS00001007877
-
NanoString nCounter® PanCancer IO 360™on anti-PD1/anti-PD1+CTLA4 in patients with metastatic melanoma
Study
EGAS00001006977
-
Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma
Study
EGAS00001006986
-
Genome-wide cell-free DNA biological patterns in patients with cancer
Study
EGAS00001007400
-
RNA sequencing in primary inflammatory (TPP) macrophages following deletion of a disease-associated gene desert at chr21q22, disruption of ETS2, or treatment of ETS2-edited macrophages with a HIF1α stabiliser.
Study
EGAS00001007553
-
Cancer of Low survival and UnMet Need – Pathologist Initiated
Study
EGAS00001008112
-
Single-cell and spatial transcriptomic profiling of hormone-naïve localised prostate cancer
Study
EGAS00001008332
-
A small cell lung cancer genome reports complex tobacco exposure signatures
Study
EGAS00000000051
-
Geographical structure and differential natural selection among North European populations
Study
EGAS00000000033
-
HG_Retroduplications_in_Neurodevelopmental_Disorders
Study
EGAS00001002907
-
NOWAC blood-based breast cancer case-control study
Study
EGAS00000000134
-
Origination of Ovarian Cancer is Dependent on Specific Aneuploidy Landscape
Study
EGAS00001007220
-
Colon cancer targeted sequencing study contaning WBCs, primary tumor tissue and plasma samples
Study
EGAS50000000059
-
Oxidative DNA damage and ubiquitin proteasome system dysfunction underpins neurodegeneration in young adults with a DNA repair disorder
Study
EGAS50000000160
-
Oxidative DNA damage and ubiquitin proteasome system dysfunction underpins neurodegeneration in young adults with a DNA repair disorder
Study
EGAS50000000162
-
Oxidative DNA damage and ubiquitin proteasome system dysfunction underpins neurodegeneration in young adults with a DNA repair disorder
Study
EGAS50000000158
-
scRNAseq data of CAP
Dataset
EGAD50000000321
-
Karyotype Evolution in Response to Chemoradiotherapy and Upon Recurrence of Esophageal Adenocarcinomas
Study
EGAS00001007711
-
Multiomic spatial landscape of innate immune cells at central nervous system borders
Study
EGAS50000000030
-
Immunomodulatory effects and improved outcomes with cisplatin- vs carboplatin-based chemotherapy plus atezolizumab in urothelial cancer
Study
EGAS50000000104
-
Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer
Study
EGAS50000000212
-
Somatic mutations of non-malignant T cells
Study
EGAS50000000237
-
Human Brain Small Extracellular Vesicles Contain Selectively-Packaged, Full-Length mRNA
Study
EGAS50000000029
-
Peripheral blood DNA methylation and transcriptomics of vedolizumab and ustekinumab treatment response in patients with Crohn's disease
Study
EGAS50000000263
-
ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium.
Study
EGAS00000000082
-
Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer
Study
EGAS50000000297
-
Single cell chromatin accessibility allows analysis of the transposable element landscape, revealing shared features of immune tissue-residency
Study
EGAS50000000350
-
Spatially resolved niche and tumor microenvironmental alterations in gastric cancer peritoneal metastases
Study
EGAS50000000501
-
Ultra-sensitive ctDNA monitoring required for predicting response and resistance to immunotherapy in advanced melanoma
Study
EGAS50000000550
-
Genome sequencing identifies splice-disrupting variants in childhood heart disease
Study
EGAS50000000586
-
MutWP6__CRUK_Grand_Challenge_Mutographs_of_Cancer__alkylating_agents
Study
EGAS00001003637
-
MutWP6__CRUK_Grand_Challenge_Mutographs_of_Cancer__oncology_agents
Study
EGAS00001004125
-
Spatial atlas of human atherosclerosis highlights role of the microvasculature in disease
Study
EGAS50000000660
-
Single-cell RNA sequencing of human skin tumors (BCC, SCC and Melanoma)
Study
EGAS50000000365
-
Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomes
Study
EGAS50000000536
-
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple negative breast cancer: phase 2 adaptive BELLINI trial. WES
Study
EGAS50000000568
-
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple negative breast cancer: phase 2 adaptive BELLINI trial. RNA-Seq
Study
EGAS50000000567
-
IL-17B uses IL-17RA and IL-17RB to induce Type-2 inflammation from human lymphocytes
Study
EGAS50000000579
-
ROCHE PD 92 Multiome dataset
Dataset
EGAD50000000964
-
Epstein-Barr Virus status drives morphological and molecular intra-tumour heterogeneity in gastric cancer: insights from a case report and literature review
Study
EGAS50000000706
-
Plasma mutation profile of precursor lesions and colorectal cancer using the Oncomine Colon cfDNA Assay
Study
EGAS50000000471
-
Single-cell Analysis of Neoplastic Plasma Cells Identifies Myeloma Pathobiology Mediators and Potential Targets
Study
EGAS50000000802
-
Cell-type eQTLs for single-cell Mendelian Randomisation
Study
EGAS50000000687
-
Multiplexing cortical brain organoids for the longitudinal dissection of developmental traits at single cell resolution
Study
EGAS50000000698
-
Oncogenic FOXL2C134W has gain-of-function chromatin remodeling activity that reprograms glucocorticoid receptor occupancy to promote ovarian granulosa cell tumor growth
Study
EGAS50000000622
-
Single cell sequencing data of PBMC and CSF from a cohort of Multiple Sclerosis patients and other neurological disease controls
Study
EGAS50000000739
-
MethylBERT enables read-level DNA methylation pattern identification and tumour deconvolution using a Transformer-based model
Study
EGAS50000000806
-
Aberrant RNA-splicing (neojunctions) offers a new source for targets, and our neoantigen discovery platform (SNIPP) characterizes a novel class of clonally-expressed splicing-derived neoantigens that elicit a CD8+ T-cell-mediated tumor killing response.
Study
EGAS00001007986
-
A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumour DNA
Study
EGAS50000000873
-
Identification and targeting of extremely high-risk gamma delta T-ALL in children
Study
EGAS50000000018
-
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: CheckMate 649 biomarker analyses
Study
EGAS50000000747
-
Sensitive neoantigen discovery by real-time mutanome-guided immunopeptidomics - RNAseq
Study
EGAS50000000977
-
Single-cell transcriptional mapping reveals genetic and hierarchy-based determinants of aberrant differentiation in AML
Study
EGAS50000000918
-
Liquid Biopsy Detection of Tumor-specific Structural Variants in High Grade Serous Ovarian Cancer
Study
EGAS50000001044
-
Genomic determinants of response and resistance to inotuzumab in B-ALL
Study
EGAS50000000067
-
Pyjacker identifies enhancer hijacking events in acute myeloid leukemia including MNX1 activation via deletion 7q
Study
EGAS50000000743
-
A single-chain derivative of the integrin β1-activating TS2/16 antibody potentiates organoid growth in Matrigel and Collagen hydrogels.
Study
EGAS50000001113
-
Spatial Transcriptomics Uncovers Tumor Microenvironment-Based Subtypes in Invasive Lobular Carcinoma
Study
EGAS50000001001
-
Direct genetic transformation bypasses tumor-associated DNA methylation alterations
Study
EGAS50000000902
-
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study
Study
EGAS50000000932
-
DNA methylation and transposable element landscapes define human regulatory T cells in tissues and identify their blood recirculating counterpart
Study
EGAS50000000738
-
Identifying genetic variants that alter TCR usage in the peripheral repertoire
Study
EGAS00001008189